Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
Authors
Keywords
-
Journal
Hepatology International
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-16
DOI
10.1007/s12072-022-10391-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
- (2022) Yusheng Guo et al. BMC CANCER
- Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
- (2022) Josep M. Llovet et al. CLINICAL CANCER RESEARCH
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
- (2021) Qiaoyun Hou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Potential predictive value of plasma heat shock protein 90α in lung cancer
- (2021) Xiaoqian Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma
- (2020) Wene Wei et al. BMC CANCER
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma
- (2020) Nicole E. Rich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma
- (2020) Guangrong Wang et al. Scientific Reports
- Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (RESCUE): a non-randomized, open-label, phase 2 trial
- (2020) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Diagnostic and prognostic value of plasma heat shock protein 90alpha in gastric cancer
- (2020) Xin-qiang Liang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
- (2019) Ping Luo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
- (2018) Zheng Wang et al. CLINICAL CANCER RESEARCH
- Hsp90α-dependent Bclaf1 promotes hepatocellular carcinoma proliferation by regulating c-MYC mRNA stability
- (2018) Xueqiong Zhou et al. HEPATOLOGY
- The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade
- (2018) Kuan-Chieh Fang et al. Liver Cancer
- HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
- (2017) Qiuran Xu et al. Molecular Cancer
- Heat Shock Proteins and Cancer
- (2017) Jianming Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
- (2017) Vatche G. Agopian et al. JAMA Surgery
- Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial
- (2017) Yan Fu et al. EBioMedicine
- Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection
- (2016) Si-Jia Wu et al. International Journal of Surgery
- Transcriptomic and Proteomic Investigation of HSP90A as a Potential Biomarker for HCC
- (2015) Yi Zhou et al. MEDICAL SCIENCE MONITOR
- Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses
- (2014) Y. Shi et al. CLINICAL CANCER RESEARCH
- Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis
- (2014) Na Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
- (2012) Edoardo G. Giannini et al. HEPATOLOGY
- Biomarkers for early diagnosis of hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET ONCOLOGY
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More